POTENCIAL DE LA PERCEPCIÓN REMOTA – ESTUDIO BASADO EN DESASTRES NATURALES OCURRIDOS DURANTE LOS ÚLTIMOS 5 AÑOS EN CHILE

A través de desastres naturales ocurridos en Chile durante los últimos 5 años se ejemplifica como observaciones adquiridas por los diversos sensores, hoy en día disponibles en la Percepción Remota, fueron utilizadas con éxito en varias ocasiones, tanto durante como después de que ha ocurrido una catástrofe. Los ejemplos presentados en el presente artículo están relacionados con el terremoto y posterior tsunami ocurrido en febrero 2010 y las erupciones volcánicas en los años 2008 y 2011. Se da a conocer las plataformas y los sensores remotos más convenientes para realizar una administración moderna de desastres naturales.Aunque el catastro de daños producidos por un desastre natural es la aplicación más conocida en público, la Percepción Remota también puede ser usada en todas las fases de su administración: Mitigación, Preparación, Respuesta y Recuperación. Por tal motivo también se muestra como y en que situación puede ser útil el uso de datosadquiridos por sensores remotos. Como la Percepción Remota puede serconsiderada como una de las más importantes herramientas en el ámbito de la administración de desastres naturales se concluye que en un país como Chile, su aplicación debe ser intensificado para poder superar cualquier catástrofe

Gene expression analysis of pancreatic cell lines reveals genes overexpressed in pancreatic cancer

Background: Pancreatic cancer is one of the leading causes of cancer-related death. Using DNA gene expression analysis based on a custom made Affymetrix cancer array, we investigated the expression pattern of both primary and established pancreatic carcinoma cell lines. Methods: We analyzed the gene expression of 5 established pancreatic cancer cell lines (AsPC-1, BxPC-3, Capan-1, Capan-2 and HPAF II) and 5 primary isolates, 1 of them derived from benign pancreatic duct cells. Results: Out of 1,540 genes which were expressed in at least 3 experiments, we found 122 genes upregulated and 18 downregulated in tumor cell lines compared to benign cells with a fold change > 3. Several of the upregulated genes (like Prefoldin 5, ADAM9 and E-cadherin) have been associated with pancreatic cancer before. The other differentially regulated genes, however, play a so far unknown role in the course of human pancreatic carcinoma. By means of immunohistochemistry we could show that thymosin [β-10 (TMSB10), upregulated in tumor cell lines, is expressed in human pancreatic carcinoma, but not in non-neoplastic pancreatic tissue, suggesting a role for TMSB10 in the carcinogenesis of pancreatic carcinoma. Conclusion: Using gene expression profiling of pancreatic cell lines we were able to identify genes differentially expressed in pancreatic adenocarcinoma, which might contribute to pancreatic cancer development.Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich

Gesellschaftlicher Aufbruch, reale Utopien und die Arbeit am Sozialen

People around the world recollect socially responsible and desirable values, new forms of living and coexistence as well as eco-social economic activities. This volume is dedicated to these real utopias –positive ideas aiming at a better future and practical approaches combining notions of a more livable society with concrete practical implementations.Weltweit besinnen sich Menschen auf gesellschaftlich Verantwortbares und Wünschenswertes, auf neue Formen des Lebens und Zusammenlebens und des ökosozialen Wirtschaftens. Dieser Band widmet sich diesen realen Utopien, positiven, in eine bessere Zukunft gerichteten Vorstellungen und praktischen Ansätzen, die Ideen von einer lebenswerteren Gesellschaft mit konkreter Praxis verbinden

Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction

Background Early detection of acute myocardial infarction (AMI) using cardiac biomarkers of myocardial necrosis remains limited since these biomarkers do not rise within the first hours from onset of AMI. We aimed to compare the temporal release pattern of the C-terminal portion of provasopressin (copeptin) with conventional cardiac biomarkers, including creatine kinase isoenzyme (CK-MB), cardiac troponin T (cTnT), and high-sensitivity cTnT (hs-cTnT), in patients with ST-elevation AMI. Methods We included 145 patients undergoing successful primary percutaneous coronary intervention (PCI) for a first ST-elevation AMI presenting within 12 h of symptom onset. Blood samples were taken on admission and at four time points within the first 24 h after PCI. Results In contrast to all other markers, copeptin levels were already elevated on admission and were higher with a shorter time from symptom onset to reperfusion and lower systolic blood pressure. Copeptin levels peaked immediately after symptom onset at a maximum of 249 pmol/L and normalized within 10 h. In contrast, CK-MB, cTnT, and hs-cTnT peaked after 14 h from symptom onset at a maximum of 275 U/L, 5.75 lg/L, and 4.16 lg/L, respectively, and decreased more gradually. Conclusions Copeptin has a distinct release pattern in patients with ST-elevation AMI, peaking within the first hour after symptom onset before conventional cardiac biomarkers and falling to normal ranges within the first day. Further studies are required to determine the exact role of copeptin in AMI suspects presenting within the first hours after symptom onset